Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

65 trials with published results (11%)

Research Maturity

336 completed trials (58% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.6%

38 terminated out of 576 trials

Success Rate

89.8%

+3.3% vs benchmark

Late-Stage Pipeline

18%

105 trials in Phase 3/4

Results Transparency

19%

65 of 336 completed with results

Key Signals

65 with results90% success38 terminated

Data Visualizations

Phase Distribution

352Total
Not Applicable (182)
Early P 1 (3)
P 1 (30)
P 2 (32)
P 3 (60)
P 4 (45)

Trial Status

Completed336
Unknown112
Terminated38
Recruiting36
Withdrawn26
Active Not Recruiting12

Trial Success Rate

89.8%

Benchmark: 86.5%

Based on 336 completed trials

Clinical Trials (576)

Showing 20 of 20 trials
NCT07645079Not ApplicableNot Yet Recruiting

Automated Insulin Delivery Versus Daily Injections for Hospital Diabetes Care

NCT02917486CompletedPrimary

EC-MOTION : ExtraCorporeal Membrane Oxygenation and Therapeutic Drug Monitoring of Drugs of infectION

NCT00342589Completed

New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia

NCT01264055CompletedPrimary

Cross-sectional Characterization of Idiopathic Bronchiectasis

NCT07603128RecruitingPrimary

Multicenter Validation of a Risk Prediction Model for MDRGNB Infection

NCT06829719Not ApplicableRecruitingPrimary

TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation

NCT00557726RecruitingPrimary

Diagnosis and Management of Inflammatory and Infectious Diseases

NCT00875069Phase 3Completed

Efficacy and Safety of Ethanol Lock Solution in Prevention of Catheter Related Bloodstream Infection for Patients Suffering Acute Renal Failure, and Hospitalized in Intensive Care Unit. A Multi-Center, Randomized, Versus Placebo, Double Blinded Clinical Trial

NCT07109856Recruiting

The Peripheral(-Muscle) Oxygenation and Perfusion Score as a New Non-invasive Tool to Predict Elevations in C-reactive Protein Levels in Neonates

NCT02283112RecruitingPrimary

Validation of Drug Assays in Various Biological Matrices

NCT07575009Phase 3RecruitingPrimary

Continuous Antibiotic Infusion In Children

NCT02085915Not ApplicableCompleted

Evaluation of the Strip PeriScreen for the Fast Diagnosis of the Spontaneous Infection of the Liquid of Ascites During the Cirrhosis

NCT06920979Not ApplicableRecruiting

Stop Sepsis Through Home Monitoring Cooperative

NCT04591366Not ApplicableActive Not RecruitingPrimary

Barrier-Protect Study

NCT07556107Phase 4Not Yet RecruitingPrimary

The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)

NCT05189925Phase 1Recruiting

NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)

NCT07125495Not ApplicableCompletedPrimary

The Effect of an Suction Toothbrush on the Development of Ventilator-Associated Pneumonia

NCT07536035Recruiting

Potential of Interface Care Models to Deliver More Appropriate Care to Patients With Acute Medical Illness

NCT02545478Recruiting

Biomarkers in Infection

NCT07484633Phase 4Not Yet RecruitingPrimary

A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients

Scroll to load more

Research Network

Activity Timeline